Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma

INTRODUCTION: The objective of this study was to evaluate real-world effectiveness of latanoprostene bunod (LBN) ophthalmic solution 0.024% in treatment-naïve patients newly diagnosed with open-angle glaucoma (OAG) or ocular hypertension. METHODS: This multicenter retrospective chart review included...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ophthalmol Ther
Главные авторы: Okeke, Constance O., Burstein, Eitan S., Trubnik, Valerie, Deom, James E., Cooper, Michael S., Brinkley, Desirae A., Thimons, J. James, Kabiri, Alexander J., Gelb, Kerry M.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Healthcare 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7708554/
https://ncbi.nlm.nih.gov/pubmed/33034885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-020-00307-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы